Atlas Trials

Prognostic Value of Anti-Ro52 Antibodies in Connective Tissue Diseases (a-Ro52)

Clinical trial NCT03565601 · UNKNOWN

Trial details

NCT number
NCT03565601
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Connective Tissue Diseases
Start date
2019-01-01
Primary completion
2020-09-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.